Sydney Lupkin

Sydney Lupkin, covers drug prices and specializes in data reporting for the Kaiser Health News enterprise team. She joined KHN from VICE News and MedPage Today. Before that, she spent several years covering health topics at and digging into data at The Bay Citizen and ProPublica. Her work has also appeared in The New York Times, The Boston Globe and the Boston Herald. She is a graduate of Boston University, where she worked at the New England Center for Investigative Reporting. In 2015, she spent a week in Southeast Asia reporting on malaria as an International Center for Journalists fellow.

Posts by Sydney Lupkin


Will pricey old drugs bust Medicaid bank?

“People always thought, ‘They’re generics. They’re cheap,’” said Matt Salo, who runs the National Association of Medicaid Directors. But with drug prices going up “across the board,” generics are far from immune.

presented by
Sponsored Post

Physician Targeting Using Real-time Data: How PurpleLab’s Alerts Can Help

By leveraging real-time data that offers unprecedented insights into physician behavior and patient outcomes, companies can gain a competitive advantage with prescribers. PurpleLab®, a healthcare analytics platform with one of the largest medical and pharmaceutical claims databases in the United States, recently announced the launch of Alerts which translates complex information into actionable insights, empowering companies to identify the right physicians to target, determine the most effective marketing strategies and ultimately improve patient care.